AntiCoagAF 17+
DOAC use in non-valvular AF
CereScape Pty Ltd
Designed for iPad
-
- $1.99
Screenshots
Description
Updated information about DOACs and their use in non-valvular atrial fibrillation management (Feb 2022), and for iOS 15.
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
What’s New
Version 1.3
Updated by Prof Bruce Campbell, University of Melbourne, for 2022 use. Added information about new DOAC reversal agents. Helpful for management of stroke, peri-operative care and other decisions involving DOAC use.
App Privacy
The developer, CereScape Pty Ltd, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Information
- Seller
- CereScape Pty Ltd
- Size
- 5.2 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 15.0 or later.
- iPad
- Requires iPadOS 15.0 or later.
- iPod touch
- Requires iOS 15.0 or later.
- Mac
- Requires macOS 12.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Frequent/Intense Medical/Treatment Information
- Copyright
- © 2013 Dr Bruce Campbell
- Price
- $1.99
Supports
-
Family Sharing
Up to six family members can use this app with Family Sharing enabled.